CERVARIX, VACCIN
VACCIN PAPILLOMAVIRUS HUMAIN [TYPES 16, 18] (RECOMBINANT, AVEC ADJUVANT, ADSORBE)
Public price
384,00 MAD
Active substance
VACCIN PAPILLOMAVIRUS HUMAIN [TYPES 16, 18] (RECOMBINANT, AVEC ADJUVANT, ADSORBE)
Laboratory
GSK
What is this medicine?
CERVARIX, VACCIN contains VACCIN PAPILLOMAVIRUS HUMAIN [TYPES 16, 18] (RECOMBINANT, AVEC ADJUVANT, ADSORBE). Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
VACCIN PAPILLOMAVIRUS HUMAIN [TYPES 16, 18] (RECOMBINANT, AVEC ADJUVANT, ADSORBE), SUSPENSION INJECTABLE EN FLACON, 0, BOITE DE 1 FLACON DE 0,5 ML
Common uses
General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Laboratory
GSK
Hospital price
255,00 MAD
Strength
0
Form
SUSPENSION INJECTABLE EN FLACON
Presentation
BOITE DE 1 FLACON DE 0,5 ML
Commercial status
Non Commercialisé
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 384,00 MAD